|
1-phosphatidylinositol 3-kinase - genetics |
4 |
|
adenocarcinoma - genetics |
4 |
|
adenocarcinoma - genetics - metabolism |
4 |
|
azacitidine - analogs & derivatives - therapeutic use |
4 |
|
bioinformatics |
4 |
|
cell line |
4 |
|
dna methylation |
4 |
|
dna modification methylases - antagonists & inhibitors |
4 |
|
dna-binding proteins - metabolism |
4 |
|
down-regulation |
4 |
|
drug synergism |
4 |
|
enzyme inhibitors - therapeutic use |
4 |
|
experimental design |
4 |
|
gastric adenocarcinoma |
4 |
|
gene expression regulation, neoplastic |
4 |
|
gene silencing |
4 |
|
helix-loop-helix motifs |
4 |
|
histone deacetylase inhibitors |
4 |
|
hmlh1 |
4 |
|
humans |
4 |
|
hydroxamic acids - therapeutic use |
4 |
|
id4 |
4 |
|
inhibitor of differentiation proteins |
4 |
|
metagenomics |
4 |
|
microarray |
4 |
|
microbiome |
4 |
|
microsatellite repeats |
4 |
|
microsatellite repeats - genetics |
4 |
|
mutation |
4 |
|
next generation sequencing |
4 |
|
promoter methylation |
4 |
|
promoter regions, genetic |
4 |
|
stomach neoplasms - genetics |
4 |
|
stomach neoplasms - genetics - metabolism |
4 |
|
transcription factors - metabolism |
4 |
|
alternative splicing |
1 |
|
chromosome 12q21 |
1 |
|
non-coding transcripts |
1 |
|
novel gene |
1 |
|
rhabdomyosarcoma |
1 |
